Skip to content

Clinical and health economic evaluation with a new Baha® abutment design combined with a minimally invasive surgical technique

Clinical and health economic evaluation with a new Baha® abutment design combined with a minimally invasive surgical technique - CBAS5439

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON45173
Enrollment
63
Registered
2012-12-28
Start date
2013-02-13
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deafness hearing loss

Interventions

The surgical placement (conventional versus the simplified surgical technique) of the comparator (Baha BA300) or investigational device (Baha BA400)

Sponsors

COCHLEAR BONE ANCHORED SOLUTIONS AB
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Adult patient, i.e. * 18 years of age * Eligible for the Baha system * Signed informed consent

Exclusion criteria

Exclusion criteria: * Patient scheduled for simultaneously bilateral implant surgery * Uncontrolled diabetes as judged by the investigator * Condition that could jeopardize osseointegration and/or wound healing, e.g. osteoporosis, psoriasis and use of corticosteroids * Unable to follow the cleaning instruction * Unable to follow investigational procedures, e.g. to complete quality of life scales * Participation in another investigation with pharmaceuticals and/or device * Condition that may have an impact on the outcome of the investigation as judged by the investigator * Suitable implant position for the 4 mm implant not found during surgery due to insufficient bone quality and/or bone thickness

Design outcomes

Primary

MeasureTime frame
The first primary endpoint, a combined endpoint of infection/inflammation, overgrowth, pain and numbness,will be evaluated by a function of the Holgers Index, the Soft tissue thickening/over-growth scale, POSAS pain scale, question regarding pain in scar/neuropathic pain and Numbness scale. The second primary variable, the costs of the surgical procedure, complications and number of extra wound dressings sessions will be evaluated by surgical time, Holgers Index and the number of extra dressing sessions. The costs will be estimated and evaluated in local currency.

Secondary

MeasureTime frame
* Wound healing * Numbness * Pain * Aesthetics * Complications * Overgrowth * Quality of Life

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)